Buy, Sell, Hold: 5 stocks on analysts’ radar today

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Shriram Trans

Brokerage: JPMorgan

The global research firm said that extensive due diligence & ongoing discussions are reasons for the extension. Further, having a structure that keeps the firm in existing avatar of a separately listed company will be a positive. In fact, the originally proposed structure would involve a more diversified business and potential holdco discount. The swap ratio would be the key, he added.

Jubilant Food

Brokerage: Morgan Stanley | Rating: Upgrade to overweight | Target: Rs 1,780

The brokerage house said that the firm was benefiting from strong demand environment. Their channel checks show favourable demand trend for quick service restaurants. It is projecting 60 percent EPS CAGR for FY17-20.

BASF

Brokerage: Emkay | Rating: Initiate with buy | Target: Rs 2,212

The brokerage said that BASF was well positioned to deliver solid performance on revenue and profitability front. Moreover, Dahej plant will spur revenue growth. It is estimating a CAGR of 13.6%/39.1% in revenue/EBITDA over FY17-20.

ShilpaMedicare

Brokerage: MOSL | Rating: Buy | Target: Rs 805

The brokerage house said that strong pipeline & forward integration will drive earnings. It expects the company to deliver US revenue of Rs 400 crore In FY20 Vs Rs 25 crore in FY17. In fact, it said that the company is well positioned in the Europe market too. Key positives are in place to drive 42% earnings CAGR over FY17-20.

Shoppers Stop

Brokerage: IDFC Securities | Rating: Outperform | Target: Rs 590

The brokerage house observed that HyperCity has been a continued drag on Shoppers Stop’s cash flows. It is viewing the stake sale to Future Retail as a major positive for the firm. In fact, factoring HyperCity sale, consolidated FY19 Sales/EBITDA stand reduced by 23%/3%.